A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors
Clinical trial NCT06736275 · RECRUITING
Trial details
- NCT number
- NCT06736275
- Sponsor
- Jiangsu Nutai Biologics Co., Ltd
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-02
- Primary completion
- 2027-10-06
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.